Damora Therapeutics, Inc. (DMRA)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-08-02 and 2026-10-31, public records show 1 signal for Damora Therapeutics, Inc.. Most notable: 2026-09-25: Jarrett Jennifer (director) bought $253k of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-10-31 from public records.

Signals, last 12 months

  1. Insider purchase
    Jarrett Jennifer (director) bought $253k of stock
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Material 8-K filing
    Filed 8-K disclosing director or officer change
  5. Material 8-K filing
    Filed 8-K disclosing material agreement
  6. Material 8-K filing
    Filed 8-K disclosing director or officer change
  7. Material 8-K filing
    Filed 8-K disclosing director or officer change
  8. Material 8-K filing
    Filed 8-K disclosing material agreement, acquisition or disposition of assets, director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-09-25Jarrett JenniferdirectorP12,50020.23$252,875
2026-07-06Winslow GarrettofficerS24529.98$7,345
2026-07-03Winslow GarrettofficerM680——
2026-03-30Jarrett JenniferdirectorA500,0000$0
2026-03-30Jarrett JenniferdirectorA500,0000$0
2026-02-09Bruno JuliannedirectorM129,0000$0
2026-02-09Fairmount Healthcare Fund II L.P.ten percent ownerM5,809,0000$0
2026-02-09Fairmount Healthcare Fund II L.P.ten percent ownerM2,904,0000$0
2026-02-09Bruno JuliannedirectorM129,0000$0
2026-02-09Fairmount Funds Management LLC; Fairmount Healthcare Fund II L.P.; Fairmount Healthcare Co-Invest V L.P.; Kiselak Tomas; Harwin Peter EvandirectorM5,809,0000$0
2026-02-09Fairmount Funds Management LLC; Fairmount Healthcare Fund II L.P.; Fairmount Healthcare Co-Invest V L.P.; Kiselak Tomas; Harwin Peter EvandirectorM2,904,0000$0
2026-01-05Sattarzadeh SherwinofficerA190,3760$0
2026-01-05Hewes L. BeckerofficerA264,6290$0
2026-01-05Sattarzadeh SherwinofficerA190,3760$0
2026-01-05Hewes L. BeckerofficerA264,6290$0
2026-01-02Schambye Hans T.directorM1,360——
2026-01-02Schambye Hans T.directorS70021.38$14,966
2026-01-02Winslow GarrettofficerS25521.38$5,452
2026-01-02Winslow GarrettofficerM680——
2026-01-02Firmani LoriofficerM374——
2026-01-02Firmani LoriofficerS13521.41$2,890
2026-01-02Schambye Hans T.directorM1,360——
2026-01-02Schambye Hans T.directorS70021.38$14,966
2026-01-02Winslow GarrettofficerM680——
2026-01-02Winslow GarrettofficerS25521.38$5,452
2026-01-02Firmani LoriofficerM374——
2026-01-02Firmani LoriofficerS13521.41$2,890
2025-07-03Schambye Hans T.directorS7353.38$2,484
2025-07-03Schambye Hans T.directorM1,360——
2025-07-03Winslow GarrettofficerM680——
2025-07-03Winslow GarrettofficerS2603.39$881
2025-07-03Firmani LoriofficerM374——
2025-07-03Firmani LoriofficerS1473.39$498
2025-07-03Schambye Hans T.directorM1,360——
2025-07-03Schambye Hans T.directorS7353.38$2,484
2025-07-03Winslow GarrettofficerM680——
2025-07-03Winslow GarrettofficerS2603.39$881
2025-07-03Firmani LoriofficerM374——
2025-07-03Firmani LoriofficerS1473.39$498
2025-01-03Winslow GarrettofficerM1,320——
2025-01-03Winslow GarrettofficerS4715.6$2,638
2025-01-03Firmani LoriofficerM726——
2025-01-03Firmani LoriofficerS2615.63$1,469
2025-01-03Schambye Hans T.directorM2,640——
2025-01-03Schambye Hans T.directorS1,3415.6$7,510
2025-01-03Winslow GarrettofficerM1,320——
2025-01-03Winslow GarrettofficerS4715.6$2,638
2025-01-03Firmani LoriofficerM726——
2025-01-03Firmani LoriofficerS2615.63$1,469
2025-01-03Schambye Hans T.directorM2,640——

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings